Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib in First-line Metastatic Pancreatic Adenocarcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Dasatinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms FOLFOX-D
- 09 Apr 2018 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 12 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2018.
- 20 Jan 2018 Final toxicity data will be presented at the meeting.